摘要:
This disclosure concerns a procedure for bulk scale preparation of high aspect ratio, 2-dimensional nano platelets comprised of a few graphene layers, Gn. n may, for example, vary between about 2 to 10. Use of these nano platelets in applications such as thermal interface materials, advanced composites, and thin film coatings provide material systems with superior mechanical, electrical, optical, thermal, and antifriction characteristics.
摘要:
Systems and methods for the preparation of reinforcements for composite materials, whereby single- and/or multi-walled carbon nanotubes (CNTs) may be electrophoretically deposited on fibrous substrates for the production of hybrid CNT/fibers. The fibers may include carbon fibers and woven carbon fabrics. The length, as well as the density and orientation of the deposited nanotubes on the fiber surfaces may also be tailored. The strength of the CNT/fiber-matrix interface formed in composites fabricated from the hybrid CNT/fibers may be adjusted by introduction of functional groups on the CNT/fiber surfaces, such as aminophenyl and carboxyphenyl groups.
摘要:
This application relates to a fusion protein, which is composed of a thrombolytic protein, an anticoagulant protein, and a linker peptide. In particular, the fusion protein is composed of an anticoagulant protein and a protein molecule having plasminogen-activating activity, wherein said two proteins are linked together via a linker peptide, which can be recognized and cleaved by blood coagulation factors. The application also relates to the medical use of said fusion protein, and to the use of the linker peptide which can be recognized by blood coagulation factor in linking a thrombolytic protein and an anticoagulation protein.
摘要:
A bifunctional catalyst for catalyzing both an oxygen reduction reaction and an oxygen evolution reaction is provided, wherein the catalyst comprises a doped graphene backbone having thiol functional groups. A method for producing a bifunctional catalyst is also provided.
摘要:
A method of producing single or few-layer graphene comprises exfoliating graphite with a polymer to form a graphene-polymer composite and subsequently treating the composite to disassociate graphene. The exfoliation process is conducted using sonication. The graphene is disassociated from the polymer by a treatment step such as acid hydrolysis. The method results in highly pure graphene.
摘要:
Provided is an anticoagulant fusion protein comprising oligopeptide recognizable and cleavable by either factor XIa and factor Xa or thrombin and factor Xa. Also provided are the preparation method of the anticoagulant fusion protein and medicinal use thereof.
摘要:
A method for preparing an electrode for use in lithium batteries and the resulting electrodes are described The method comprises coating a slurry of silicon, sulfur doped graphene and polyacrylonitrile on a current collector followed by sluggish heat treatment.
摘要:
An all graphene battery is disclosed. The battery is designed into a form of a belt and can charge multiple portable electric devices simultaneously. The battery has a graphene based anode, a graphene composite based cathode. The electrolyte of the battery is gel like functionalized graphene oxide. The device of this disclosure may use thermoelectric effect to charge itself. The battery of this disclosure is safe, and has a high capacity, high energy density and long life time. The battery includes no liquids and is light weighted.
摘要:
Hydrophobic and oleophilic compositions are provided. The compositions may be used for absorption of oil from water or organic solvents from water or oil/solvent from any emulsion. The compositions could also have high conductivity and may be used as supercapacitors. Methods to make the compositions are also provided.
摘要:
This application relates to a fusion protein, which is composed of a thrombolytic protein, an anticoagulant protein, and a linker peptide. In particular, the fusion protein is composed of an anticoagulant protein and a protein molecule having plasminogen-activating activity, wherein said two proteins are linked together via a linker peptide, which can be recognized and cleaved by blood coagulation factors. The application also relates to the medical use of said fusion protein, and to the use of the linker peptide which can be recognized by blood coagulation factor in linking a thrombolytic protein and an anticoagulation protein.